These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7527506)

  • 1. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
    Ogawa T; Yorioka N; Yamakido M
    Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
    Takahashi T; Inaba S; Okada T
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
    Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
    Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
    J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5b-9 and adhesion molecules in human idiopathic membranous nephropathy.
    Papagianni AA; Alexopoulos E; Leontsini M; Papadimitriou M
    Nephrol Dial Transplant; 2002 Jan; 17(1):57-63. PubMed ID: 11773463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.
    Schulze M; Donadio JV; Pruchno CJ; Baker PJ; Johnson RJ; Stahl RA; Watkins S; Martin DC; Wurzner R; Gotze O
    Kidney Int; 1991 Sep; 40(3):533-8. PubMed ID: 1787650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular response to injury in membranous nephropathy.
    Nangaku M; Shankland SJ; Couser WG
    J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectron microscopic localization of membrane attack complex and hepatitis B e antigen in membranous nephropathy.
    Akano N; Yoshioka K; Aya N; Miyamoto H; Takemura T; Tohda M; Maki S
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):325-30. PubMed ID: 2496520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions.
    Sobel RA; Chen M; Maeda A; Hinojoza JR
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):202-13. PubMed ID: 7533209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal distribution of mesangium-specific laminin in glomeruli of patients with idiopathic membranous nephropathy.
    Horikoshi S; Ebihara I; Nakamura T; Koide H
    Nephron; 1999; 81(3):284-8. PubMed ID: 10050082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of membranous nephropathy.
    Couser WG; Abrass CK
    Annu Rev Med; 1988; 39():517-30. PubMed ID: 2967047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Hanamura K; Tojo A; Kinugasa S; Asaba K; Onozato ML; Uozaki H; Fukayama M; Fujita T
    Hum Pathol; 2011 May; 42(5):649-58. PubMed ID: 21292302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of extracellular matrix receptors in various forms of glomerulonephritis.
    Shikata K; Makino H; Morioka S; Kashitani T; Hirata K; Ota Z; Wada J; Kanwar YS
    Am J Kidney Dis; 1995 May; 25(5):680-8. PubMed ID: 7538261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation products in the circulation and urine of primary membranous nephropathy.
    Zhang MF; Huang J; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Cui Z; Liu G; Zhao MH
    BMC Nephrol; 2019 Aug; 20(1):313. PubMed ID: 31399080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-morphologic heterogeneity of minimal changes in glomerulonephritis].
    Shestakova LA; Varshavskiĭ VA
    Arkh Patol; 1994; 56(6):22-8. PubMed ID: 7605213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5b-9 deposition in children with glomerular diseases.
    Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
    Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy.
    Neale TJ; Rüger BM; Macaulay H; Dunbar PR; Hasan Q; Bourke A; Murray-McIntosh RP; Kitching AR
    Am J Pathol; 1995 Jun; 146(6):1444-54. PubMed ID: 7778683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.